Reporting quality of clinical practice guidelines regarding gout and hyperuricemia according to the RIGHT checklist: systematic review

Can Wang, Xufei Luo, Maichao Li, Lingling Cui, Xinde Li, Lin Han, Xuefeng Wang, Wei Ren, Yuwei He, Wenyan Sun, Changgui Li, Yaolong Chen, Zhen LiuSystematic 2021 · DOI

TL;DR

This systematic review assessed the reporting quality of clinical practice guidelines (CPGs) for gout and hyperuricemia using the RIGHT checklist. The findings reveal that most CPGs have poor reporting quality, with significant gaps in crucial areas like funding and quality assurance, potentially hindering their effective implementation and increasing the risk of misdiagnosis or inappropriate treatment.

What Problem Does This Paper Address?

Clinical practice guidelines (CPGs) are essential tools for standardizing medical care, ensuring evidence-based decision-making, and improving patient outcomes. However, the quality of these guidelines can vary significantly, impacting their reliability and usefulness. For conditions like gout and hyperuricemia, which are prevalent and associated with substantial morbidity, high-quality CPGs are crucial. While tools like the AGREE II instrument assess the methodological rigor of CPG development, they don't specifically focus on the clarity and completeness of the reported information. The RIGHT (Reporting Items for Practice Guidelines in Healthcare) checklist was developed to address this gap by providing a comprehensive framework for reporting CPGs. This paper aims to evaluate the reporting quality of existing gout and hyperuricemia CPGs using the RIGHT checklist to identify areas for improvement and guide the development of future, higher-quality guidelines.

Methods

The researchers conducted a systematic review of clinical practice guidelines (CPGs) for gout and hyperuricemia published between January 2009 and June 2019. They searched multiple databases (PubMed, CBM, Wanfang, CNKI) and websites of guideline development organizations (GIN, NICE, ACR, EULAR). The study employed the RIGHT checklist, which comprises 22 key items and 35 sub-items categorized into seven domains: basic information, background, evidence, recommendations, review and quality assurance, funding and declaration, and other information. Two researchers independently screened and extracted data, with discrepancies resolved through discussion. Each item was graded as "reported" (Y), "unreported" (N), "partially reported" (P), or "not applicable" (NA). The quality of an item was considered low if its reporting proportion was less than 50%.

Datasets

The study did not involve the creation or use of new datasets for training or evaluation. Instead, it analyzed a collection of existing clinical practice guidelines (CPGs) related to gout and hyperuricemia.

Key Insights and Ideas

  • RIGHT Checklist's Value: The study highlights the RIGHT checklist's utility in identifying specific reporting deficiencies that might be overlooked by broader methodological assessments like AGREE II.
  • Poor Overall Reporting: The most striking insight is the consistently low reporting quality across the evaluated CPGs, suggesting a systemic issue in how these guidelines are documented.
  • Domain-Specific Weaknesses: While basic information is generally well-reported, critical areas like "review and quality assurance" and "funding and declaration and management of interests" are significantly neglected. This suggests a tendency to focus on the content of recommendations without adequately detailing the processes that ensure their reliability and transparency.
  • Geographical and Organizational Differences: The study observed variations in reporting quality based on the geographical origin of the CPGs and the developing organizations, indicating that certain regions or institutions may have more robust reporting practices.
  • Improvement Over Time: There's a positive trend showing improved reporting quality in more recently published guidelines, suggesting that awareness and adherence to reporting standards are gradually increasing.

Key Results

  • Seventeen CPGs were included in the analysis, with one in Chinese and 16 in English.
  • The mean reporting rate across all 35 RIGHT items was 14.9 (42.5%).
  • Only five CPGs (29.4%) achieved a reporting rate above 50%.
  • The best-performing CPG reported 62.9% of the items, while the poorest two reported less than 26%.
  • The most frequently reported items were related to the basis of the guideline (item #11a), assessing evidence certainty (item #12), and the strength of recommendations (item #13c), all reported in over 94% of guidelines.
  • The least reported items were #8b (specific environment for which the guide is intended) and #17 (quality assurance process), which were reported in none of the CPGs.
  • Reporting rates for the seven domains were: basic information (64.7%), evidence (50.6%), recommendations (42.9%), background (36.8%), funding and declaration (33.8%), other information (31.4%), and review and quality assurance (8.82%).

Limitations and Future Work

Limitations:

  • Language Bias: The study was limited to CPGs published in English and Chinese, potentially excluding relevant guidelines from other languages.
  • Scope of Sources: Only CPGs published in journals and online were analyzed; guidelines published as books or government documents were not included.

Future Work:

The authors strongly recommend that organizations involved in developing CPGs for gout and hyperuricemia adopt the RIGHT reporting checklist. This will help standardize reporting, ensure clarity, completeness, and transparency, and ultimately improve the quality and usability of future guidelines. Further research could explore the impact of improved reporting on guideline implementation and patient outcomes.

Summary updated

Abstract

The reporting quality of the present guidelines for gout and hyperuricemia is relatively poor. We suggest that the RIGHT reporting checklist should be used by CPG developers to ensure higher reporting quality of future guidelines.
BibTeX
@inproceedings{wang2021reporting,
  author = {Can Wang and Xufei Luo and Maichao Li and Lingling Cui and Xinde Li and Lin Han and Xuefeng Wang and Wei Ren and Yuwei He and Wenyan Sun and Changgui Li and Yaolong Chen and Zhen Liu},
  title = {{Reporting quality of clinical practice guidelines regarding gout and hyperuricemia according to the RIGHT checklist: systematic review}},
  booktitle = {Systematic},
  year = {2021},
  doi = {10.1186/s13643-021-01645-1},
}
Figure